GALENA BIOPHARMA INC COM
RXII
RXII was delisted on the 25th of October, 2011.
90 hedge funds and large institutions have $68.9M invested in GALENA BIOPHARMA INC COM in 2014 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 24 increasing their positions, 30 reducing their positions, and 16 closing their positions.
19% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 16
2% more funds holding
Funds holding: 88 → 90 (+2)
3% more call options, than puts
Call options by funds: $13.7M | Put options by funds: $13.3M
19% less capital invested
Capital invested by funds: $84.7M → $68.9M (-$15.8M)
20% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 30
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.75M |
| 2 |
SGAM
Smith Group Asset Management
Dallas,
Texas
|
+$1.7M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.53M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$1.18M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$675K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$17M |
| 2 |
CCM
Consonance Capital Management
New York
|
-$13.6M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.35M |
| 4 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$1.32M |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
-$1.15M |
RXII Hedge Fund Activity: Q2 2014 in Review
90 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in GALENA BIOPHARMA INC COM (RXII) for Q2 2014, worth a combined $68.9M — down 19% from $84.7M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new RXII positions and 16 closed out — a net gain of 3 holders — while 24 added to existing stakes and 30 trimmed.
The largest buyer was Vanguard Group, adding an estimated $1.75M. The largest seller was State Street, cutting an estimated $17M.
- 90 institutional investors held GALENA BIOPHARMA INC COM (RXII) as of Q2 2014, up from 88 in Q1 2014.
- Funds reported $68.9M of GALENA BIOPHARMA INC COM stock for Q2 2014, down 19% quarter-over-quarter.
- 19 funds opened new GALENA BIOPHARMA INC COM positions in Q2 2014 and 16 closed out, a net change of +3 holders.
- The largest GALENA BIOPHARMA INC COM buyer in Q2 2014 was Vanguard Group, an estimated $1.75M added.
- The largest GALENA BIOPHARMA INC COM seller in Q2 2014 was State Street, an estimated $17M sold.
Based on aggregated 13F filings for Q2 2014.